Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 3, 2009, Pages 735-743

  Wang, K ^a,b   Chen, Y ^a   Liu, S ^a   Qiu, S ^c   Gao, S ^a   Huang, X ^a,b   Zhang, J ^a,b   Peng, X ^d   Qiani, W ^a   Zhang, Jian Ying ^a,b  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Immunoreactivity; Ra1A; Tissue expression; Tumor associated antigen

Indexed keywords

AUTOANTIBODY; PROTEIN RA1A; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE SPECIFICITY;

ADULT; AGED; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RAL GTP-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 70350556969     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200319     Document Type: Article

References (24)

1. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998; 187:1163-1167
2. Fernàndez Madrid F, Tang N, Alansari H, Karvonen RL, Tomkiel JE. Improved approach to identify cancer-associated autoantigens. Autoimmu Rev 2005; 4:230-235 (Pubitemid 40704708)
3. Bodemann BO, White MA. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 2008; 8:133-140
4. Chen Y. Identification of tumor-associated antigens as markers for immunodiagnosis of human cancers. http://digitalcommons.utep.edu/dissertations/ AAI3262904/ [accessed 2007].
5. Johnson PJ, Leung N, Cheng P, Welby C, Leung WT, Lau WY, Yu S, Ho S. 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer 1997; 75:236-240
6. Zhang JY, Chan EK, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999; 189: 1101-1110
7. Gordis L. Assessing the validity and reliability of diagnostic and screening tests. In: L. Gordis (Eds.), Epidemiology (2nd edition), W.B. Saunders Company, Philadelphia, Pennsylvania 2000, p 63-81.
8. Wolthuis RM, Zwartkruis F, Moen TC, Bos JL. Ras-dependent activation of the small GTPase Ral. Curr Biol 1998; 8:471-474 (Pubitemid 28181126)
9. Feig LA, Urano T, Cantor S. Evidence for a Ras/Ral signaling cascade. Trends Biochem Sci 1996; 21: 438-441
10. Reuther GW, Der CJ. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol 2000; 12:157-165
11. Clerk A, Sugden PH. Ras: The stress and the strain, J. Mol Cell Cardiol 2006; 41:595-600.
12. Ceriani M, Scandiuzzi C, Amigoni L, Tisi R, Berruti G, Martegani E. Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase. Exp Cell Res 2007; 313:2293-2307 (Pubitemid 46891467)
13. Shields JM, Pruitt K, Mcfall A, Shuab A, Der CJ. Understanding Ras: 'it ain't over 'til it's over' Trends Cell Biol 2000; 10:147-154
14. Cascone I, Selimoglu R, Ozdemir C, Del Nery E, Yeaman C, White M, Camonis J. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RaI GEFs, EMBO J 2008; 27: 2375-2387
15. Chien Y, White MA. Ral GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 2003; 4:800-806 (Pubitemid 37063189)
16. Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH, White MA. Ral GTPase contributes to regulation of Cyclin D1 through activation of NF-KappaB. Mol Cell Biol 2000; 20:8084-8092
17. Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA. An EGF receptor/ Ral-GTPase signaling cascade regulates c- Src activity and substrate specificity. EMBO J 2000; 19:623-630 (Pubitemid 30093735)
18. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, Der CJ, Counter CM. Activation of Ra1A is critical for Ras- induced tumorigenesis of human cells. Cancer Cell 2005; 7:533-545 (Pubitemid 40799247)
19. Ward Y, Wang W, Woodhouse E, Linnoila I, Liotta L, Kelly K. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol 2001; 21:5958-5969 (Pubitemid 32737812)
20. Gildea JJ, Harding MA, Seraj MJ, Guiding KM, Theodorescu D. The role of RalA in epidermal growth factor receptor-regulated cell motility. Cancer Res 2002; 62:982-985 (Pubitemid 34160273)
21. Tchevkina E, Agapova L, Dyakova N, Martinjuk A, Komelkov A, Tatosyan A. The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 2005; 24:329-335 (Pubitemid 40188581)
22. Shen Y, Xu L, Foster DA. Role for phospholipase D in receptor-mediated endocytosis. Mol Cell Biol 2001; 21:595-602.
23. Sullivan CA, Chung GG. Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques. Clin Colorectal Cancer 2008; 7:172-177
24. Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Andersen J, Overgaard J. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. Acta Oncol 2008; 47:591-599